Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 109, Issue 4, Pages 1044-1054
Publisher
Wiley
Online
2018-02-16
DOI
10.1111/cas.13538
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway
- (2017) Jia-Xing Zhang et al. Molecular Cancer
- MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability
- (2017) L Liu et al. ONCOGENE
- MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner
- (2017) Wei Jin et al. Cell Death & Disease
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD
- (2016) Mingxia Zhu et al. Molecular Medicine Reports
- LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2
- (2015) Baohui Liu et al. BRAIN RESEARCH
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ligand-Independent EGFR Signaling
- (2015) G. Guo et al. CANCER RESEARCH
- Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation
- (2015) Takatsugu Ishimoto et al. INTERNATIONAL JOURNAL OF CANCER
- Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth
- (2015) M M Morrison et al. ONCOGENE
- Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin
- (2015) ZEJUN YAN et al. ONCOLOGY REPORTS
- The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer
- (2015) Yulong Shang et al. Oncotarget
- EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1)
- (2014) Tzyh-Chyuan Hour et al. ARCHIVES OF TOXICOLOGY
- Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
- (2014) D Lindquist et al. BRITISH JOURNAL OF CANCER
- Inhibition of miR-17 and miR-20a by Oridonin Triggers Apoptosis and Reverses Chemoresistance by Derepressing BIM-S
- (2014) H. Weng et al. CANCER RESEARCH
- Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer
- (2014) P. A. Thompson et al. CANCER RESEARCH
- MGr1-Ag/37LRP induces cell adhesion-mediated drug resistance through FAK/PI3K and MAPK pathway in gastric cancer
- (2014) Li Sun et al. CANCER SCIENCE
- Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer
- (2014) Lin Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2
- (2014) Z Wang et al. ONCOGENE
- LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
- (2013) Y Wang et al. BRITISH JOURNAL OF CANCER
- The Long and Short of MicroRNA
- (2013) Luke A. Yates et al. CELL
- Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis
- (2013) Lin Zhou et al. FASEB JOURNAL
- miR-20a triggers metastasis of gallbladder carcinoma
- (2013) Yanxin Chang et al. JOURNAL OF HEPATOLOGY
- LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling
- (2013) J J-C Sheu et al. ONCOGENE
- miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1
- (2013) Y Shang et al. ONCOGENE
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNF Expression and Receptor Tyrosine Kinase Signaling
- (2012) L. Bai et al. CANCER RESEARCH
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor
- (2012) Anne E. Powell et al. CELL
- The role of microRNAs in cancers of the upper gastrointestinal tract
- (2012) Shumei Song et al. Nature Reviews Gastroenterology & Hepatology
- miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines
- (2011) H. Chai et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ER -Positive Breast Cancer
- (2011) S. R. Krig et al. MOLECULAR CANCER RESEARCH
- miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
- (2010) Wei Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer
- (2008) J. K. Miller et al. CANCER RESEARCH
- Inhibition of PI3K/Akt partially leads to the inhibition of PrPC-induced drug resistance in gastric cancer cells
- (2008) Jie Liang et al. FEBS Journal
- miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
- (2008) Lin Xia et al. INTERNATIONAL JOURNAL OF CANCER
- LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
- (2008) M A Stutz et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started